Menu

Blog

Archive for the ‘biotech/medical’ category

Feb 7, 2023

The NIH-led research response to COVID-19

Posted by in categories: biotech/medical, government, health

An excellent overview of the story of how the U.S. responded to the COVID-19 pandemic along with suggestions for ways to continue making strides in combatting SARS-CoV-2 as well as how we may prepare for future emerging pathogens. The article provides an interesting case study on mechanisms of large-scale human organization, examines ways that we have succeeded in managing so many moving pieces, and explores ways that we could do better in the future. #nih #health #medicine #government #biotechnology


Investment, collaboration, and coordination have been key.

Francis Collins [email protected], Stacey Adam, […], Christine Colvis, Elizabeth Desrosiers, […], Ruxandra Draghia-Akli, Anthony Fauci, Maria Freire, Gary Gibbons, Matthew Hall, […], Eric Hughes, Kathrin Jansen, Michael Kurilla, H. Clifford Lane, Douglas Lowy, Peter Marks, Joseph Menetski, William Pao, Eliseo Pérez-Stable, Lisa Purcell, Sarah Read, Joni Rutter, Michael Santos, Tara Schwetz, Jeffrey Shuren, Timothy Stenzel, Paul Stoffels, Lawrence Tabak, Karen Tountas, Bruce Tromberg, David Wholley, Janet Woodcock, and John Young +29 authors +27 authors +22 authors fewer Authors Info & Affiliations

Continue reading “The NIH-led research response to COVID-19” »

Feb 7, 2023

Scientist Who Gene Edited Human Babies Says Mistakes Were Made

Posted by in categories: biotech/medical, genetics, law enforcement

Chinese geneticist He Jiankui rocked the scientific world with his gene-edited baby experiments back in 2018, a highly controversial use of the technology that ended up sending him to a three-year stint in prison for illegal medical practices.

Now, just under a year after being released, He has some regrets about rushing into the experiments.

“I did it too quickly,” He told the South China Morning Post in a new interview.

Feb 7, 2023

DNA’s Histone Spools Hint at How Complex Cells Evolved

Posted by in categories: biotech/medical, evolution

New work shows that histones, long treated as boring spools for DNA, sit at the center of the origin story of eukaryotes and continue to play important roles in evolution and disease.

Feb 7, 2023

How brain computations can inspire new paths in AI — Part 1

Posted by in categories: biotech/medical, robotics/AI

Gabriel kreiman; harvard university, children’s hospital boston.

Feb 7, 2023

Lixte Biotechnology Holdings, Inc. Reports That Its Lead Clinical Compound, Lb-100, Can Kill Cancer Cells Through Hyper-Stimulation of Cell Proliferation Signals in Pre-Clinical Models

Posted by in category: biotech/medical

—THE STUDY ESTABLISHES A NOVEL CONCEPT OF “TUMOR SUPPRESSIVE DRUG RESISTANCE”

—THE COMBINATION OF LB-100 WITH INHIBITORS OF CELLULAR STRESS RESPONSE MODULATORS WAS HIGHLY EFFECTIVE IN KILLING CANCER CELLS IN SEVERAL PRE-CLINICAL CANCER MODELS

—RESISTANCE TO THIS THERAPY CAN RESULT IN THE LOSS OF THE ONCOGENIC PROPERTIES OF CANCER CELLS

Feb 7, 2023

Finding Affordable Cures for Disease

Posted by in category: biotech/medical

How DAOs can change the face of science.

Feb 7, 2023

Scientists find a new way to predict cancer risk in people

Posted by in category: biotech/medical

People can lower their risks of getting many common kinds of cancer by making healthy choices. Screening tests can find some cancers early when treatment works best. Vaccines (shots) can help prevent several kinds of cancer. Learn more about how to lower your risk of getting cancer.

Feb 7, 2023

Loren Mosher M.D. talks about Soteria Project and non-drug treatments for Schizophrenia

Posted by in categories: biotech/medical, education, neuroscience

Dr. Loren Mosher, in an interview for “Changing Our Minds” (http://www.changingourmindsmovie.com for complete DVD), a documentary on mental health, talks about the Soteria project, a long term study on alternative, non-neuroleptic drug treatments for schizophrenia. Purchase the complete DVD at http://www.changingourmindsmovie.com

Feb 7, 2023

Potential therapeutic target for schizophrenia identified

Posted by in categories: biotech/medical, genetics, neuroscience

Targeting calcium signaling in neurons represents a promising therapeutic approach for treating a rare form of schizophrenia, according to a Northwestern Medicine study published in Biological Psychiatry.

“This is the first time that human are made and characterized from with the 16p11.2 duplication, one of the most prominent genetic risk factors in schizophrenia, and the first time that signaling is found as a central abnormality in schizophrenia neurons,” said Peter Penzes, Ph.D., the Ruth and Evelyn Dunbar Professor of Psychiatry and Behavioral Sciences and senior author of the study.

Schizophrenia is characterized by auditory and visual hallucinations, delusions, and trouble with forming and sorting thoughts, which severely impacts productivity and overall quality of life. The disease, which affects roughly one percent of the , has strong genetic associations, however the exact genes involved are unknown.

Feb 7, 2023

Bioelectric networks underlie the intelligence of the body

Posted by in category: biotech/medical

This is a talk given to the Department of Biotechnology at Indian Institute of Technology Madras in January 2023.

Page 1 of 2,02312345678Last